XM does not provide services to residents of the United States of America.

Oil nudges up on escalating Ukraine war, signs of improving China demand



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Oil nudges up on escalating Ukraine war, signs of improving China demand</title></head><body>

By Laila Kearney

Nov 20 (Reuters) -Oil edged up on Wednesday amid an escalation in the Ukraine war and signs of growing Chinese crude imports, while rising U.S. crude stocks checked overall price gains.

Brent LCOc1 crude futures gained 9 cents, or 0.1%, to $73.40 a barrel by 0003 GMT. U.S. West Texas Intermediate crude futures CLc1 rose 14 cents, or 0.2%, to $69.53 per barrel.

U.S. crude oil stocks were seen rising by 4.75 million barrels in the week ended Nov. 15, market sources said on Tuesday, citing American Petroleum Institute figures. Gasoline inventories, however, fell by 2.48 million barrels.

Distillate stocks also fell, shedding 688,000 barrels last week, the sources said. Official government data is due later on Wednesday.

The escalating war between major oil producer Russia and Ukraine appears to have supported prices.

On Tuesday, Ukraine used U.S. ATACMS missiles to strike Russian territory for the first time, Moscow said. Russian President Vladimir Putin lowered the bar for a possible nuclear attack.

"This marks a renewed build up in tensions in the Russia-Ukraine war and brings back into focus the risk of supply disruptions in the oil market," ANZ analysts said in a note to clients.

Signs that China, the world's largest crude importer, may have stepped up oil purchases this month after a period of weak imports boosted oil price sentiment.

Data from vessel tracker Kpler showed China's crude imports are on track to end November at or close to record highs, an analyst told Reuters.

Weak imports by China so far this year have pulled down oil prices, with Brent sinking 20% from its April peak of more than $92 a barrel.




Reporting by Laila Kearney in New York; Editing by Sonali Paul & Shri Navaratnam

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.